Neueste Einblicke

We are thrilled to announce that, for the second year in a row, we have won the ClearlyRated Best of Staffing Client and Talent Awards for providing superior service to our clients and candidates.

The U.S. market for cell and gene therapies is estimated to reach $25.58 billion by 2028, with the FDA set to approve 20 cell and 31 gene therapies in 2024.

Oxford weighs in on how AI solutions from Google Cloud can help relieve tensions around healthcare billing concerns.

A nuclear fuel consortium experienced a crane incident during a facility expansion, and determined that they needed to perform an external review of all IROF safety procedures and protocols and rewrite their IROFs.

INDUSTRY Life Sciences SERVICES Data Migration SKILLS Data Migration CSV Technical Writing The Challenge A multinational pharmaceutical provider created a […]

INDUSTRY Life Sciences SERVICES Mergers & Acquisitions Auditing SKILLS Project Management Technical Reviews Non-Conformance Reporting The Challenge During an acquisition, […]

Discover the future of asset and wealth management with FinTech. Learn how it can optimize efficiency, accessibility, and personalization.

Finding the right talent in a remote location in Germany presents a unique set of challenges. Learn how Oxford delivered the right people.

In this whitepaper, you will learn how implementing or streamlining eQMS software can create greater efficiencies, strengthen your compliance to regulations and standards, and reduce errors.

AI and Big Data are transforming the financial services industry. As the technology evolves, your business should be prepared to evolve, too.

Controls engineering is increasingly pivoting toward sophisticated automation, integrating AI and ML to enhance efficiency, accuracy, and adaptability.

IoT advancements in pharma and life sciences hold the promise of enhanced drug development, real-time patient monitoring, and improved health outcomes.